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ABSTRACT 
Cysticercosis caused by Taenia solium is a common zoonotic parasitic disease in Latin 
America, Asia, Africa, and parts of Oceania, and it is responsible for many   cases of epileptic 
seizures. Imaging techniques used to diagnose neurocysticercosis (NCC) are expensive and 
therefore rarely  available in endemic countries. Several reliable methods have been 
developed for diagnosis of cysticercosis, and these include the use of recombinant antigens. 
Commercial antigens for diagnosing human NCC are obtained from either a soluble 
parasite extract or a parasite-derived glycoprotein fraction.   
In this study, we identified and evaluated the antigens Tsol-p27 (previously detected in 
Nicaragua) and cC1 as potential recombinant diagnostic reagents, and we also investigated 
the localization and partial function of Tsol-p27. Immunoblotting using recombinant Tsol-
p27 revealed that Tsol-p27 was recognized by antibodies in all 10 analysed serum samples 
from NCC-positive individuals, whereas recombinant cC1 was recognized in only five of 
the 10 Tsol-p27-positive sera. None of the negative control sera showed a positive reaction 
to either of the recombinant antigens.  
We also used immunoelectrotransfer blot (EITB) to analyse serum samples from 165 
people in Mozambique. This assessment confirmed that 18 of the subjects were NCC 
positive  and the remaining 147 were NCC negative. Furthermore, Western blot analysis of 
Tsol-p27 showed 85.71% sensitivity and 96.69% specificity. 
 
Despite the limited number of serum samples evaluated in the present studies, the results 
suggest that Tsol-p27 antigen provides good sensitivity and specificity and can thus be 
considered a suitable candidate for diagnosis of human NCC in both Central America and 
sub-Saharan Africa. 
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ABBREVIATIONS 
2-DE two-dimensional electrophoresis 
cDNA complementary DNA 
CHAPS 3-[(3-cholamidopropyl)dimethylammonio]-1-propane-sulphonate 
CNS central nervous system 
CT computed tomography 
DNA deoxyribonucleic acid 
DTT dithiothreitol    
E. coli Escherichia coli 
E. granulosus  Echinococcus granulosus 
E. multilocularis Echinococcus multilocularis 
EITB enzyme-linked immunoelectrotransfer blot 
ELISA enzyme-linked immunosorbent assay 
ESA Eastern and Southern Africa 
GST glutathione S-transferase 
IEF isoelectric focusing 
Ig Immunoglobulin 
IPG immobilized pH gradient   
IPTG isopropyl B-thiogalactopyranoside 
kDa kilodalton    
LC–MSMS liquid chromatography–mass spectrometry 
NCC Neurocysticercosis 
NCBI National Center for Biotechnology Information (USA) 
ORF open reading frame 
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SDS-PAGE sodium dodecyl sulphate polyacrylamide gel electrophoresis 
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1 INTRODUCTION 
 
History 
Cysticercosis and taeniasis were known in antiquity but described in the literature           
only a few centuries ago. Aristophanes and Aristotle referred to porcine 
cysticercosis in 380−375 BC when they described the occurrence of cysticerci in 
the human tongue detected by palpation [1]. An Egyptian papyrus document         
from 1500 BC made allusions to illnesses known at the time, one of which was no 
doubt caused by Taenia solium. Also, ancient Hebrew Scriptures prohibited the 
consumption of pork, because most early Jewish people had a boar as a totem and 
probably had no idea of the role that parasites play in human health [1, 2].   
The first case of human cysticercosis to be clearly identified was                   
reported in 1558, and cysticerci was recognized as parasite in 1697. A link 
between taeniasis and cysticercosis in the same patient was observed in 1782, 
and the life cycle of T. solium was described three years later [1, 2]. 
 
General background 
Taeniasis and cysticercosis constitute an important public health problem because 
they occur primarily in low-income countries, where the persistence of the infection is 
promoted by various cultural and socio-economic factors, as well as poor sanitary 
conditions [3]. Taenia infection is endemic in many countries in Central and South 
America, Asia, Africa, and parts of Oceania, affecting thousands of individuals and 
representing the major cause of epilepsy worldwide [3, 4].  
Humans and pigs can develop cysticercosis by ingesting eggs of the zoonotic 
cestode T. solium. Cysticercosis is one of the few infectious diseases that can be 
eradicated, and it is the target of control programmes in many countries [5]. The fact 
that T. solium cysticercosis is often overlooked as a possible cause of epilepsy, 
along with the scarcity of reliable diagnostic techniques, explains why human 
cysticercosis remains an underestimated public health problem [6]. One of the main 
difficulties associated with controlling T. solium cysticercosis is that people in 
endemic areas lack knowledge about this infection. In short, the majority of 
individuals in those regions are not aware of the relationship between the intestinal 
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tapeworm in pigs (known as “solitaria”) and cysticercosis in pigs and humans, and 
hence they do not understand the danger in of eating Cysticercus-infected pork, and 
some even prefer such meat for its particular flavour [7].  
Neurocysticercosis (NCC) is caused by the presence of T. solium larvae in the 
central nervous system (CNS). NCC is the most widespread parasitic disease of the 
human brain, and it is responsible for most cases of adult-onset epilepsy in the world 
[8]. It has been estimated that annual work productivity is reduced by up to 30% in 
people with NCC-induced epilepsy [9].  
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2 ETIOLOGY  
 
Morphology 
The pork tapeworm belongs to the kingdom Animalia, the phylum Platyhelminthes, 
the class Eucestoda, the order Cyclophyllidea, and the family Taenidae, and it has 
been given the genus and species names of Taenia solium [10]  
The adult tapeworm: In this stage, T. solium is a flat, segmented, hermaphroditic 
parasite that is 2 to 10 meters long and is found in the human small intestine. The 
worm is composed of a head or scolex that is approximately 1 mm in diameter and 
bears four muscular suckers that enable attachment and to some extent also 
locomotion [11, 12]. Anterior to the suckers is an armed rostellum armed with 22 to 
36 hooks ordered in two rows. A thin neck about 5 to 10 mm in diameter is 
responsible for most of the biokinetics  of the tapeworm, as well as formation of the          
strobila that make up the rest of the body [12]. The strobila consists of between 800 
and 4.000 proglottids or segments, which can be grouped as immature, mature, and 
gravid. Immature proglottids are wider than they are long; mature proglottids  are 
square in shape and contain mature primary sexual organs; gravid proglottids are 
rectangular in shape (longer than wide) and most of their sexual organs are 
atrophied, and they are filled almost entirely with branched uteri packed with 
spherical eggs called oncospheres [11]. 
Oncospheres: Oncospheres are 29 to 77 µm in diameter. An oncosphere is 
composed of a chorionic membrane, a thick and grooved embryophore surrounded 
by embryophoric blocks (consisting of keratin-like protein), an embryophoric 
membrane, and two oncospheral membranes that envelope the oncosphere (also 
called a hexacanth embryo), which bears three pairs of hooks [11]. 
Cysticerci: Cysticerci located in the brain and muscle of both humans and pigs 
exhibit the same morphological characteristics. A cysticercus consists of an ovoid 
vesicle that is approximately 5–15 mm in diameter, has a transparent outer 
membrane, and is filled with a colourless fluid and contains an invaginated scolex 
(with four suckers and an armed rostellum with two rows of hooks). The wall of the       
cysticerci is a membranous structure composed of a cuticle or external layer, a 
cellular or middle layer, and a reticular or internal layer [13]. 
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Life cycle 
The life cycle of T. solium involves two hosts (Fig. 1): humans are the only 
definitive hosts for the adult tapeworm, whereas both pigs and humans can serve 
as intermediate hosts for the larval form. In the normal cycle of transmission, the 
adult T. solium inhabits the small intestine of humans, where it is attached to the 
intestinal wall by its strong suckers and hooks. Gravid proglottids are detached 
from the distal end of the worm and are passed in the host’s faeces to liberate 
thousands of fertile eggs in the surrounding environment. In low-income areas with 
poor sanitation, the food that is eaten by pigs is often contaminated with human 
faeces containing T. solium eggs [14].  
After T. solium eggs have reached the intestinal tract of a pig, they lose their 
protective coats and liberate oncospheres that cross the intestinal wall and enter 
the pig’s bloodstream, and are subsequently carried to the tissues and evolve into 
cysticerci. If improperly cooked infected pork is consumed by a human, cysticerci 
are released in the small intestine, where, under the action of the host’s digestive 
enzymes, the scolices evaginate and attach to the intestinal wall. Thereafter, the 
proglottids begin to multiply and become mature tapeworms within approximately 
four months [15].  
Humans can also be intermediate hosts for T. solium, and such infection is called 
human cysticercosis/neurocysticercosis [4]. Cysticercosis can occur through 
ingestion of food contaminated with T. solium eggs or by the faecal-oral route in a 
human harbouring an adult T. solium in the intestine. Indeed, recent 
epidemiological studies have shown clustering of patients with cysticercosis around 
individuals with taeniasis, which has changed previous concepts that pinpointed 
the environment as the main source of human contamination with T. solium eggs. 
Thus human cysticercosis should be considered as an infection transmitted mainly 
from person to person, and the role of infected pork is to perpetuate the infection 
[5] 
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Figure 1. The life cycle of Taenia solium. (From CDC: http://www.dpd.cdc.gov) 
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3 CLINICAL ASPECTS 
  
Taeniasis 
The most noticeable sign of taeniasis is the presence of proglottids either in the 
faeces or actively migrating out of the host. A few gravid T. solium are released in 
the host’s faeces once a day or two or three times a week. Taeniasis per se causes 
low morbidity and is usually asymptomatic, although people with the disease have 
reported prurits in the peri-anal region, abdominal pain, distension, nausea and 
diarrhoea [16].    
Human cysticercosis  
Neurological symptoms are the most important characteristic of human T. solium 
cysticercosis. About 50–70% of patients with cysticerci localized to the CNS are 
asymptomatic, and epilepsy is the most common clinical manifestation of NCC in 
symptomatic patients [17]. Additional symptoms described are nausea, migraine, 
mental disorders, nervous hypertension, endocrinal hypertension, and paralysis [18], 
[19].  
Subcutaneous cysticercosis entails typical larvae-containing nodules that are 
painless for the host but surrounded by varying degrees of inflammation. Cysts in 
muscles cause severe pain, especially if the parasite load is heavy, and the larval 
stage  can also become established in the myocardium [20]. In the eyes, retinal and 
vitreous involvement occur most frequently, followed by sub-retinal, conjunctival, and 
anterior segment localization, and the first-mentioned can lead to uveitis, iritis, and 
retinitis and can also affect the muscles of the eye [21].       
Porcine cysticercosis 
Cysticercosis-related symptoms are usually not manifested when cysticerci are 
present in muscles or adjacent tissues. Nevertheless, reports indicate that common 
symptoms in experimentally infected pigs include anorexia, fever, bradycardia with 
increased respiratory rate, nausea, and diarrhoea, as well as abortion and death in 
cases of massive infestation [22], [23].  
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4 EPIDEMIOLOGY 
 
Human cysticercosis is associated with resource-limited settings where people eat 
raw or undercooked pork and traditional pig husbandry is practised. Furthermore,       
transmission of the disease is facilitated by poor hygiene and inadequate sanitation, 
as well as the use of untreated or partially treated wastewater in agriculture [24]. 
Today, the regions with the highest prevalence are Latin America, Southeast Asia, 
Africa, and Eastern Europe, and therefore tourism and immigration from endemic 
countries has led to emergence of cysticercosis in some high-income countries [25]. 
 T. solium cysticercosis is widely distributed in many parts of Africa where it is 
customary to raise pigs. Swine production has increased significantly in the Eastern 
and Southern Africa (ESA) region during the past decade, especially in rural, 
resource-poor smallholder communities [6]. Concurrent with the rise in smallholder 
pig keeping and pork consumption, there have been increasing reports of porcine 
and human cysticercosis in Western and Central Africa and the ESA countries           
[6], [26].  
In Mozambique, swine production is driven predominantly by smallholders, 
particularly in the central part of the country. Pigs are generally kept under extensive 
(free-range) conditions in which the animals obtain food primarily by scavenging and 
normally have access to primitive housing only at night. Inspection and control of 
pork is limited due to lack of slaughterhouse facilities. Together, these circumstances 
favour perpetuation and spreading of T. solium, which poses a serious                         
public health risk for the population in general [27].  
Data concerning human cysticercosis in Mozambique are scarce. In one 
investigation [28], anti-Cysticercus cellulosae antibodies were detected in 20.8% of 
the children living in the urban environments of Maputo. Another study conducted in 
1993 showed that 12.1% of patients and visitors at Maputo Central Hospital were 
positive for antibodies against Cysticercus cellulosae [29].  
12 
 
Figure 2. The epidemiology of cysticercosis. (From WHO:              
http://gamapserver.who.int/mapLibrary/Files/Maps/Global_cysticercosis_2009.png) 
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5 DIAGNOSIS  
 
Taeniasis 
Several methods have been developed to identify intestinal taeniasis. Macroscopic 
diagnosis entails searching for proglottids in faeces or recovery of       a worm after 
treatment. Routine diagnosis is based on microscopic detection of Taenia spp. 
oncospheres in direct smears or after concentration performed using various 
approaches, such as Kato/Katz and formol-ether methods, that have a sensitivity of 
around 38% to 60% [3]. However, these methods do not allow differentiation 
between T. solium and T. saginata, which instead requires      identification       of 
adult tapeworms or proglottids [30]. Notably, highly specific polymerase chain 
reaction (PCR) methods for detection the DNA of different Taenia species were 
developed a few years ago, but those assays have not been properly validated in the 
field [31, 32]. 
   
Cysticercosis 
Ante mortem diagnosis in pigs is often done by visual inspection and tongue 
palpation. Due to their coprophagous habits, pigs are often massively infested with 
cysticerci in all parts of the body, including the brain [33]. Both ante and post mortem 
examinations offer high sensitivity and specificity if the animals have extensive 
infections, whereas those techniques provide considerably lower sensitivity when 
applied to pigs with limited infections [34].  
Immunodiagnostic methods have been developed that use antibodies to detect T. 
solium cysticercus antigen in serum and cerebrospinal fluid from humans and 
animals. EITB for cysticercosis is  regarded as the gold standard assay for 
serological identification of this infection and is considered to offer the highest 
sensitivity and specificity [34-36]. However, this test is based on a complex of native 
proteins employed in immunoblot assay formats, which have not yet been        
successfully adapted for use under field conditions. Due to the high cost of EITB, 
several enzyme-linked immunosorbent assays (ELISAs) for antibody detection have 
been developed that use crude antigens, purified T. solium antigens, and synthetic 
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peptides [37, 38]. These assays have shown high sensitivity and specificity, but they 
are only able to identify presence of the vesicular larval stage. 
In recent years, the use of magnetic resonance imaging (MRI) and computed 
tomography (CT) has enabled  diagnosis of NCC cases with a benign course              
that would not have been detected previously. These techniques allow detailed 
assessment of viable, degenerated, and calcified cysticerci or lesions in the human 
CNS, but they are expensive and not widely  available in endemic countries, where 
there is also a scarcity of skilled experts to interpret CT and MRI images [39]. 
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6 PREVENTION AND CONTROL  
 
In 2002, the World Health Organization (WHO) formulated measures to control NCC 
based on the following knowledge [40]: the larval stage of the pork tapeworm is the 
causative agent of cysticercosis; cysticercosis is the most important parasite-induced 
neurological condition in humans; human cysticercosis is associated with poverty in 
areas where pigs are raised under free-range conditions; cysticercosis of the CNS is 
an important cause of chronic epilepsy. Notably, several characteristics of 
cysticercosis make it a potential target for eradication: humans are the only definitive 
host of the parasite; humans carriers are the sole source of infection for intermediate 
hosts; transmission of the infection from pigs to humans can be controlled; there are 
no important wild reservoirs of the parasite [41, 42]. In addition, there are practical 
methods for surveillance in pigs (e.g., tongue palpation), and EITB and copro-
antigen techniques  can be used in humans. Moreover, there are safe and effective 
drugs for mass chemotherapy of taeniasis and cysticercosis in pigs [43]. 
Efforts should be made to reduce of T. solium by improving human hygiene and 
sanitation. Examination of the tongues of pigs in slaughterhouses represents an 
inexpensive strategy to rapidly detect infection foci and thereby determine where 
interventions are needed. Farmers must be convinced that it would be of financial 
benefit to raise pigs more hygienically, and evidence is required to support that 
assertion [43]. In a study conducted in the Angonia District in Mozambique [27], it 
was found that porcine cysticercosis could be effectively controlled by treating                                          
pigs with oxfendazoIe, but it was also concluded that such an approach needs to be 
integrated with other control measures, including health education for the target 
population and treatment of human tapeworm carriers. In Mozambique, a serious 
constraint is that national programmes to control or eliminate cysticercosis are 
lacking due to economic  obstacles in the form of slaughterhouse facilities, poor 
sanitary conditions, and scarcity of affordable diagnostic methods.  
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7 AIMS  
The general objective of the studies included in this thesis was to develop and 
improve methods for diagnosis of cysticercosis. More specific aims were as 
follows: 
 
• To identify immunoreactive proteins from Taenia solium cysts (Paper I). 
• To validate an immunodiagnostic test for human cysticercosis (Paper II). 
 
 
 
 
  17 
8 MATERIAL AND METHODS 
 
Source of antigen 
Paper I: Intact T. solium cysts used for determination of immunogenic proteins were 
obtained from naturally infected pigs raised in an endemic area of Mozambique. The 
cysts were washed with phosphate-buffered saline (PBS; pH 7.5) and kept at –80 °C 
until used. Briefly, cysticerci were mechanically disrupted in 500 µl of PBS and 
homogenized with a protease inhibitor cocktail (Invitrogen®). The sample was 
subsequently centrifuged at 13,000 x g for 10 min at 4 ºC, and the supernatant was 
stored at –20 ºC. 
Sources of human sera 
A total of 181 serum samples were collected from patients in Mozambique as 
described below. 
Paper I: Sera were obtained from 20 epileptic patients who lived in Tete Province 
and were found to be positive or negative for NCC by Ag ELISA. The patients were 
also examined individually by computed tomography (CT)   and, based on the results 
of both tests, their serum samples were divided into a NCC-positive group (n = 10) 
and a NCC-negative control group (n = 10) [7]. 
Paper II: One hundred sixty-five serum samples from patients in Tete and Sofala 
Provinces were used to evaluate the efficacy of an immunoblot method.  
 
Two-dimensional electrophoresis (2-DE) 
Paper I: IPG strips with a linear pH range of 4–10 or 4–7 (GE Healthcare) were 
rehydrated for 12 h according to the manufacturer’s protocol. The extracted proteins 
were mixed with rehydration buffer containing 6 M urea, 2 M thiourea, 2% (w/v) 
CHAPS, 0.4% (w/v) DTT, and 0.002% (w/v) bromophenol blue. The isoelectric 
focusing (IEF) was performed using a Multiphor system (Pharmacia Biotech) and the 
following conditions: 200 V for 20 min, 450 V for 15 min, 750 V for 15 min, and 2,000 
V for 30 min. In the second dimension, the strips from IEF were loaded for sodium 
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dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE; 12%) according to 
the protocol provided by the manufacturer (Pharmacia Biotech).   
 
Western blot analysis and protein sequencing 
Paper I: After 2-DE, the acrylamide gels were directly stained with Coomassie Blue 
(Bio Rad) or were transferred to nitrocellulose membranes (GE Healthcare). 
Membranes blotted with proteins separated by 2-DE or proteins blotted with 
recombinant cC1 or recombinant Tsol-27 antigens were blocked for 2 h with 5% 
skim milk in PBS (blocking solution) and subsequently rinsed in PBS and 0.05% 
Tween 20 (washing solution). Thereafter, the membranes were incubated for 3 h 
with human sera diluted 1:500 in blocking solution and then for 1 h with rabbit anti-
human IgG conjugated with peroxidase (Sigma) diluted 1:3,000 in blocking solution. 
Detection was performed according to the ECL plus manual (GE Healthcare).  
The blotted proteins that reacted with positive sera were identified by comparing with 
Coomassie-stained gel. The protein spots exhibiting the greatest immunoreactivity 
were selected, excised from the gel, and stored at –20 °C.  Later, the excised spots 
were trypsinized, and the proteins were subjected to amino acid sequencing by liquid 
chromatography–mass spectrometry (LC–MS).  
 
Cloning, expression, and purification of recombinant proteins 
Papers I and II: Recombinant Tsol-p27 and cC1 proteins were produced from 
selected cDNA and amplified using specific primers. For cC1, we used the primer 
pair cC1F 5'- CTC GGA TCC ATG GCC TAC TGT CGC TCC CTG- 3`(sense)/cC1 R 
5`-CGG GAA TTC CGG TGC AGG GCC GAT GAG TTT CA-3`(antisense). The 
Tsol-p27 protein was expressed as previously described [44]. All PCR experiments 
were performed using a Thermo Hybrid system and Maxima Hot Start PCR 
2xMaster Mix (Fermentas). The PCR conditions were as follows: one cycle at 96 °C 
for 5 min followed by 30 cycles at 96 °C for 45 s, 52 °C for 45 s, 72 °C for 1 min, and 
72 °C for 7 min. The cC1-amplified ORF was cloned into pTrcHis2 C (Life 
Technologies) and expressed as a recombinant protein. The recombinant cC1 was 
purified using his-selected nickel magnetic beads (Sigma). The resin was 
equilibrated with a buffer containing 50 mM sodium phosphate (pH 8.0), 0.3 M 
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sodium chloride, and 10 mM imidazole, and then eluted with a higher concentration 
of imidazole (250 mM). The histidine-containing proteins were separated from the 
fraction by applying a magnetic separator to the mixed solution. The Tsol-p27 was 
purified in parallel as described previously [45].  
 
Polyclonal sera produced in rabbits  
Paper I: The recombinant Tsol-p27 protein was expressed as glutathione S-
transferase (GST) fusion protein and then purified and used to raise polyclonal 
antibodies in rabbits as previously described [45], 46].  
In short, on days 0, 28, 56, and 84, each of two male rabbits received four 
immunizations with the recombinant proteins (250 µg/rabbit) emulsified in 250 µl of 
Freund’s complete (first immunization) or incomplete (second to fourth immunization) 
adjuvant. Sera collected before immunizations were used as negative control. Serum 
was separated and stored at –20°C until used.  
Western blot analysis 
Paper I: Western blot analysis of anti-rabbit Tsol-p27 immune sera was performed 
essentially as in our earlier study [44], with the following changes: extracts from adult 
tapeworms and cysticerci were separated by 10% SDS-PAGE and transferred to 
nitrocellulose membranes (Sigma). The blots were washed and incubated for 1 h 
with the anti-rabbit IgG conjugated with peroxidase (Sigma) and diluted 1:6,000 in 
5% skim milk-PBS. After washing, the membranes were stained with 3,3',5,5'-
tetramethylbenzidine (TMB; Sigma). 
Immunohistochemistry 
Paper I: The anti-rabbit Tsol-p27 immune sera were also used to localize the Tsol-
p27 proteins in T. solium cysticerci. The cysticerci used in this study were dissected 
from the muscles of a naturally infected pig and then washed in PBS (pH 7.5). Only 
cysticerci that exhibited a vesicular appearance were selected for the study, and 
they were stored at –20 °C until used. Ribbons of 8-µm sections of the T. solium 
cysticerci were placed on slides, and then treated as follows: air dried for 20 min, 
fixed in acetone for 20 min, dried for 15 min at room temperature, and thereafter 
rehydrated in PBS. Anti-rabbit Tsol-p27 or TsolHSP36 immune serum diluted 1:40 in 
PBS was added to the slides, which were subsequently incubated for 45 min. As a 
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negative control, pre-immune sera were used at the same dilution and incubation 
time. After the incubation, the slides were washed 2 x 15 min in PBS and then 
incubated for 45 min with fluorescein isothiocyanate (FITC)-labelled anti-rabbit IgG 
(Sigma) diluted 1:40 in Evans blue solution. Lastly, the slides were washed 2 x 15 
min and examined in a fluorescence microscope (Leica Microsystems).      
 
Amino acid sequencing analysis 
Paper I: Sequencing analysis of Tsol-p27 was performed at the National Center for 
Biotechnology Information (NCBI; Bethesda, MD, USA) using the BLAST search 
option with a cut off of 10–5. To obtain the family domain description corresponding to 
Tsol-p27, a cut-off of 10–9 was employed in the search option.  
 
Ethics 
The use of human samples was approved by the Ethics Committee of the Faculty of 
Medicine of Eduardo Mondlane University and the National Committee on 
Biomedical Research Ethics of the Ministry of Health of Mozambique. 
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9 RESULTS  
 
Paper I: Identification of immunoreactive proteins from T. solium  
Soluble antigens from T. solium cysticerci were separated according to isoelectric 
point (pI, range 4–7) and size (MW), and were thereafter visualized by Coomassie 
Blue staining (Fig. 3) and transferred to nitrocellulose membranes. The membranes 
were then probed with sera from NCC-positive or NCC-negative patients (Fig. 3). 
Proteins that reacted with NCC-positive but not NCC-negative sera were cut out of 
the Coomassie-stained gel and subjected to partial amino acid sequencing. 
  
 
Figure 3. 2-DE Western blot analysis of T. solium cysticerci. (A) A 2-DE gel stained 
with Coomassie Blue showing soluble cysticerci proteins with pI values in the range 
4–7. (B) Corresponding Western blot probed with serum from a patient diagnosed 
with NCC. (C) Corresponding Western blot probed with serum from a control subject. 
Arrows indicate the proteins that were isolated and sequenced.  
Six proteins cut out of the gel were subjected to LC–MSM analysis. The amino acid 
sequences from several peptides, derived from each of the selected proteins, were 
determined (Table 1). The peptide sequences were identified as possible proteins, 
determined by the degree of homology to other known proteins. The following 
proteins were identified: tropomyosin, enolase related to T. asiatica, cC1 antigen, 
actin, heat shock protein p36, and Tsol-p27 related to T. solium  (Table 1). 
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Table 1. Identified proteins recognized by NCC-positive human sera 
Spot 
no. 
Protein 
identity 
GenBank 
accession/Organism  
Amino acid sequence MW 
(kDa) 
pI 
      
1 Tropomyosin ABN14948.1/ (K)AINLENQLK(E) 32.2 4.7 
  T. asiatica (K)NIQTEVDTVQESLQEAISK(L)   
   (R)ATNAEAEVAAMTR(R)   
   (R)LLEEDFEQSSGR(L)   
   (R)MAQLEEQVK(E)   
   (K)YIAEDAER(K)   
   (R)LAVTEVDLER(A)   
   (K)IVELEEELR(I)   
   (K)SLEVSEQESLQR(E)   
   (R)EESYEETIR(D)   
   (K)LQNEVDRLEDELLSEK(E)   
      
2 Enolase ACX56268/T.  (K)LGANAILGVSLAVCK(A) 47 6.2 
  asiatica (K)LAMQEFMILPTGAK(N)   
   SGETEDSTIADIVVGLR   
   (K)HIADLAGNK(N)   
   (K)ACNALLLK(V)   
   (K)YNQLLR(I)   
   (K)VNQIGSVTESIK(A)   
   (R)AAVPSGASTGVHEAVELR(D)   
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   (K)IGMDVASSEFYQDGK(Y)   
   LAEIYLEMLSK   
   IEEELGSK   
      
3 cC1 antigen  AAD34598.1/T.  NLTPSTLSQVVNPGLAETDAK 37.9 5.7 
  solium EALLLALAGQADEPQAMQLK   
   SFLQLNATNEAYNR   
   YAELYGETLEAAIK   
   ADTDLGSIK   
   DAYPSISSK   
   FALLLIQSPWQVMAEALYDAMK   
   VLNEIIAGCSK   
   SLVHLYAPNGEK   
   TLHDALTSELSGK   
   GDTSGDYEALCLK   
   ASLFAELLHFAMR   
   AFEEVSGGETLDDAIK   
   ELYACGEGRPGTAESR   
      
4 Actin AAA30092.1 (R)VAPEEHPVLLTEAPLNPK(A) 41.7 5.3 
  T. solium (R)GYSFTTTAER(E)   
   (K)YPIEHAIVTNWDDMEK(I)   
   (K)QEYDESGPSIVHR(K)   
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   (K)LCYVALDFEQEMATAASSSSLEK(S)  
   (K)IWHHTFYNELR(V)   
   (K)EITSLAPSTMK(I)   
   (K)IVAPPER(K)   
   (K)AGFAGDDAPR(A)   
   (K)DSYVGDEAQSK(R)   
      
5 Heat shock        Q7YZT0/ 
protein p36        T. solium  
(R)NLFSLEPFTAMDNAFESVMK 35.5 5.7 
   (R)EFHPELEYTQPGELDFLK(D)   
   (K)SVACGDAAMSESVGR(S)   
   (K)GLAIQPSEVQER(Q)   
   (R)SIPLPPSVDR(N)   
   (K)VYVHGVTGK(E)   
   (K)EMSAIQPR(E)   
   (K)VYFNVK(N)   
      
6 Tsol-p27 AEF14021.1/T.solium (R)TSDLIHEIDQMK(A) 27 5.0 
   (K)IITATEEFVDINIASK(V)   
   (K)LGTALEQVASQSEK(A)   
   (K)NFLNTTLSEAQK(A)   
   (K)EFDGLSVQLLDLIR(A)   
   (K)NYYEACAK(E)   
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Three of the identified proteins were excluded from further investigations because 
they were extremely conserved and were also found in other parasitic worms and in 
humans. TsolHSP36 and Tsol-p27 were also detected in a previous study in 
Nicaragua [44], which suggested  that Tsol-p27 would be a suitable candidate for 
diagnosis of NCC. The third protein chosen to be evaluated and expressed as a 
recombinant protein in the present investigation was cC1 . Purified Tsol-p27 on 
Western blot strips was recognized by antibodies in all serum samples from the 
NCC-positive control group (Fig. 4), whereas purified cC1 on such strips was 
detected by antibodies present in only 50% of the the NCC-positive sera (Fig. 4); 
neither of those recombinant proteins reacted with  any antibodies present in the 
sera from the healthy control group.  
 
Figure 4. Immunoblot analysis of recombinant Tsol-p27 (A and B) and cC1 (C and D) 
antigens. (A and C) Probing done with serum (diluted 1:500) from patients 
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diagnosed as NCC positive by CT (lanes 1–4). (B and D) Probing done with serum 
(diluted 1:500) from patients diagnosed as NCC negative by CT. 
 
Paper I: Localization of polyclonal antibodies raised against Tsol-p27 
To determine the specificity of antibodies raised against Tsol-p27, Western blot 
analyses were carried out using extracts of cysticerci and adult tapeworms. The size 
of the protein was predicted to be 27 kDa. The Western blotting of both the 
cysticercus and adult stage extracts detected  the Tsol-p27 protein as a single band 
of 27 kDa (Fig. 5A, C). Pre-immune serum was used as a negative control (Fig. 5B, 
D).  
 
Figure 5. Western blot analysis of extracts of T. solium cysticerci (A) and adult 
tapeworms (B) using anti-rabbit Tsol-p27 immune serum (lanes 1 and 3) and pre-
immune serum as negative control (lanes 2 and 4). 
Immunofluorescence detection of antibodies raised against Tsol-p27 antigen was 
used to localize the proteins in T. solium cysticercus tissue. As shown in Figure 6, 
the reaction of antibodies to the protein was seen as intense green fluorescence 
over the parenchymal folds and the tegument of the spiral canal in T. solium 
cysticerci, whereas no fluorescent reaction was observed when pre-immune serum 
was tested.   
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Figure 6. Sections of Taenia solium cysticerci examined by phase contrast 
microscopy and FITC staining. The arrows in panels A and B indicate the 
parenchymal folds (PF) and tegument of the spiral canal (TSC). (B) An image 
obtained using rabbit anti-Tsol-p27 antibodies, and structures are indicated as in 
panels A and B. (C) Image showing the results obtained when using pre-immune 
sera as controls.  
 
  
 28 
Paper 2:  Performance of Tsol-P27 antigen for serology diagnosis of 
cysticercosis in Mozambique       
A total of 161 serum samples from the Angonia District and Beira City in central 
Mozambique were investigated. Fourteen of the samples were positive and 147 
negative for Tsol-p27 anti-Tsol-p27 antibodies by EITB assay. Western blotting 
showed both higher sensitivity and higher specificity compared to the commercial 
ELISA for analysis of Tsol-p27 (Table 2). Furthermore, the Western blot results were 
similar to those previously obtained for Tsol-p27 in Central America: 80.00% 
sensitivity and 96.69% specificity in Mozambique versus 86.7% sensitivity and 
97.8% specificity in Nicaragua. If four positive samples from paper 1 are added, the 
sensitivity increases to 85.71% while the specificity remains the same. By 
comparison, the ELISA used in Mozambique provided 15.38% sensitivity and 
85.14% specificity.  
Table 2. Detection of antibodies against T. solium cysticerci in serum samples by 
two different immunodiagnostic tests compared with the gold standard method EITB. 
*The number of positive samples when samples from Paper 1 are added.  
 
 EITB 
 Positive Negative Total 
Commercial ELISA    
Positive 2 22 24 
Negative 11 126 137 
Total 13 92 161 
Western blot     
Positive 8 (12)* 5 13(17)* 
Negative 2 146 148 
Total 10 (14)* 151 161 
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10 DISCUSSION  
Immunodiagnosis of human cysticercosis has been accomplished using a variety of 
antigens and methods, including ELISA, dot blot, and EITB [47-50]. Among the tests 
that have been developed, EITB is considered to be the most specific and is 
therefore also regarded as the gold standard. This technique uses an enriched 
fraction of glycoproteins prepared from cysticerci by lectin affinity purification [48]. 
However, the main drawbacks of EITB are the cost and the   reproducibility when 
investigating serum samples from patients carrying only one or a few cysts. 
Therefore, research projects have been focused on developing new serological 
diagnostic tools that offer sensitivity and specificity, and are easy to perform in poorly 
equipped laboratories. The aim of  the present project was to improve the diagnosis 
of cysticercosis in rural settings.  
Here, the protein Tsol-p27 was addressed as a promising novel candidate for future 
use in diagnosis of NCC. In our work, the Tsol-p27 antigen was efficiently expressed 
in E. coli as a fusion protein and was purified in two steps using glutathione-agarose 
and his-selected nickel beads, respectively. We found that Western blotting was 
comparable to commercial ELISA for analysis of Tsol-p27, with regard to both 
specificity and sensitivity. In previous research conducted by our team in [45], it was 
noted that the Tsol-p27 antigen showed potential for diagnosis of human 
cysticercosis. Similar to those results, the current Western blot analyses based on a 
population in Mozambique that the Tsol-p27 antigen was identified by antibodies in 
serum from NCC patients, but not by antibodies in serum from a control group. 
There is evidence that using ELISA or other immune diagnostic methods to detect 
specific antibodies against T. solium in serum can be a useful tool for identifying 
cysticercosis in humans. However, the commercial ELISA we used provided very 
poor results, that is, it identified only two of 14 patients that were positive for NCC by 
EITB assay. An explanation for this low sensitivity might be that the serum samples 
that were analysed came from patients carrying very few cysts, or even that the 
ELISA applied used antigens from pigs infected with T. solium. Such porcine-derived 
material can vary in quality, and in our study might have represented a batch of 
proteins that were less immune reactive or were partially degraded during the 
production process. Indeed, the T. solium antigens currently used for diagnosis of 
human cysticercosis are derived from parasites extracted from infected pork [48]. It 
is plausible that recombinant antigens can serve as a simplified, low-cost substitute 
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for the native antigens, and also provide a reproducible diagnostic assay that can be 
employed in the field.  
 
11 CONCLUDING REMARKS  
 
Paper I: In this study, Tsol-p27 and cC1 were identified, and serum samples were 
evaluated. Although the number of samples assessed was limited, Tsol-p27 was 
identified as a potential candidate for  diagnosis of  cysticercosis. Therefore, it can 
be recommended that a larger number of samples be  evaluated. The function of 
Tsol-p27 might be related to a variety of biological processes that involve membrane 
sorting, fusion, and transport. Furthermore, this protein might aid and promote the 
growth of the adult tapeworm within the human intestine. 
 
Paper II: For evaluation of Tsol-p27, the Western blot analysis performed well in 
comparison with the other diagnostic tests that were assessed. Importantly, Western 
blotting is simpler to use and less expensive than ELISA and EITB, and it would be 
relatively easy to implement the Western blot Tsol-p27 assay in poorly equipped 
laboratories in low-income countries. 
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